2020 Speakers Included

2020 Speakers Included

Stephen M. Hahn, Commissioner, U.S. Food & Drug Administration (FDA)

Jessica Mega, Chief Medical & Scientific Officer, Verily

Stéphane Bancel, CEO, Moderna Therapeutics

Susan Shiff, SVP - Centre for Observational and Real World Evidence, MSD

Robert Bradway, Chairman and CEO, Amgen

Terry Wilcox, Executive Director, Patients Rising

David Lennon, President, Novartis Gene Therapies

Natalie Kofler, Founder, Editing Nature

Bernard Hamelin, Global Head - Medical Evidence Generation, Sanofi-Aventis Group

Mike DeLone, Principal - US Life Sciences Sector, Deloitte

Peter Bach, Director of Center for Health Policy & Outcomes, Memorial Sloan Kettering Cancer Center

Everett Neville, Senior Vice President, Value Creation, Cigna

Will Lewis, Chair & CEO, Insmed

Sandy Macrae, President and CEO, Sangamo Therapeutics

Ofer Leidner, Co-founder and President, Happify Health

Suneet Varma, Global President, Rare Disease Business Unit, Pfizer

Florian Brand, Co-founder and CEO, ATAI Life Sciences

Kimberly Haugstad, CEO, Global Genes

Julia Hoffman, Vice President - Behavioural Health Strategy, Livongo

Rich Carter, Senior Director - Digital Health, Eli Lilly and Company

Joanne Waldstreicher, Chief Medical Officer, Johnson & Johnson

Mary Rozenman, Chief Financial Officer, Insitro

Alexander Hardy, CEO, Genentech Inc.

Kim Branson, Senior Vice President and Global Head of AI/ML, GSK

FT moderators included:

Sarah Neville, Global Pharmaceuticals Editor, FT

Hannah Kuchler, US Pharma and Biotech Correspondent, FT

Clive Cookson, Science Editor, FT

Donato Mancini, Reporter, FT

VP - Biopharma, Capital One Healthcare
“Interviews with public officials were poignant and refreshingly genuine - don't see that too often these days!”